Recent studies have highlighted the importance of assessing MYC rearrangement in aggressive B-cell lymphomas, mainly DLBCL, as well as the detection of protein expression [3, 14, 18–20]. Here, MYC is linked to B-cell non-Hodgkin lymphoma.